Trials / Completed
CompletedNCT01056042
Efficacy of Injectable Contraceptive and Oral Contraceptive Administered After Surgical Treatment of Endometriosis With Pain
Postoperative Intramuscular Depot Medroxyprogesterone Acetate Versus Continuous Oral Contraceptive for Pelvic Pain Associated With Endometriosis : Randomized Comparative Trial.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 112 (estimated)
- Sponsor
- Prince of Songkla University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Patients with endometriosis-associated pain have conservative surgery performed to remove all visible lesions. Then, patients are randomized into two groups. In the first group patients have depot medroxyprogesterone acetate injections every 3 months for a total of 6 months.In the second group patients have oral contraceptive combined pills everyday for 6 months. Patients are followed up on recurrence of pain for 1 year after medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | intramuscular depot medroxyprogesterone acetate | 150 mg, Intramuscular, every 3 months |
| DRUG | ethinyl estradiol 30 micrograms, gestodene 75 micrograms | one tablet orally, everyday |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2011-04-01
- Completion
- 2011-10-01
- First posted
- 2010-01-26
- Last updated
- 2014-10-29
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01056042. Inclusion in this directory is not an endorsement.